What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2026-04-14 compared with 2025-03-31 · 38 added, 24 removed, 19 unchanged (77% of the section changed)

5 unchanged sentences

Holders of the Company’s Common Stock

As of March 27, 2025, we had 31 shareholders of record

As of April 13, 2026, we had 23 shareholders of record

of the Company’s Common Stock, one of which was Cede & Co., a nominee for Depository Trust Company (“DTC”).

6 unchanged sentences

The declaration or payment of dividends,

if any, in the future, will be at the discretion of DSC’s Board of Directors and will depend on the then- current financial condition,

results of operations, capital requirements and other factors deemed relevant by the Board.

Each share of Series A Preferred Stock entitles

its holder to receive cash dividends at a rate of ten percent (10%) per annum on the original issue price, compounding annually, in preference

to holders of common stock.

if any, in the future, will be at the discretion of the Company’s Board of Directors and will depend on the then- current financial

condition, results of operations, capital requirements and other factors deemed relevant by the Board.

Each share of Series A Preferred

Stock entitles its holder to receive cash dividends at a rate of ten percent (10%) per annum on the original issue price, compounding

annually, in preference to holders of Common Stock.

Preferred dividends are accrued quarterly.

No shares of Series A Preferred Stock are outstanding, and no dividends

have been paid to date since May 2021 when all of the then outstanding shares of Series A Preferred Stock were converted into shares of

the Company’s common stock.

No shares of Series A Preferred Stock are

outstanding, and no dividends have been paid to date since May 2021 when all of the then outstanding shares of Series A Preferred Stock

were converted into shares of the Company’s Common Stock.

Recent Sales of Unregistered Securities

The Company did not sell any equity securities during

the three months ended, or the fiscal year ended, December 31, 2024, that were not registered under the Securities Act, other than as previously

disclosed in its filings with the Securities and Exchange Commission (the “SEC”).

the three months ended, or the fiscal year ended, December 31, 2025, that were not registered under the Securities Act, other than as

previously disclosed in its filings with the Securities and Exchange Commission (the “SEC”).

Issuer Purchases of Equity Securities

There were no issuer purchases of equity securities

during the year ended, December 31, 2024.

On December 8, 2025, we commenced a fixed-price issuer

tender offer to repurchase up to 6,192,990 shares of Common Stock at a per share price of $5.20, representing approximately 83% of

our issued and outstanding shares of Common Stock as of December 1, 2025, for a maximum aggregate purchase price of $32,203,548.

The Tender Offer expired on January 12, 2026.

All shares purchased pursuant to the Tender Offer settled in January 2026.

In accordance with the terms and conditions of the

Tender Offer, and based on the final count, on January 15, 2026, we accepted for purchase 5,625,129 shares of Common Stock

at a fixed purchase price of $5.20 per share, for an aggregate cost of $29,250,971, excluding fees, excise taxes, and expenses related

to the Tender Offer.

The shares purchased represent approximately 72.0% of the total number of shares of Common Stock

outstanding as of December 8, 2025.

Following payment for all tendered shares, we had 2,167,138 shares of Common Stock

After completing the Tender Offer and all related payments, we retained over $10.0 million in cash.

Other than routine shares withheld to satisfy tax-withholding

obligations upon vesting of equity awards, we did not repurchase any other shares during the quarter ended December 31, 2025

On January 14, 2026, our directors and officers tendered

the following number of shares of Common Stock beneficially owned by them in connection with the Tender Offer:

Matthew Grover

Thomas Kempster

Lawrence Maglione

Uwayne Mitchell

Charles Piluso

Nancy Stallone

Clifford Stein

Harold Schwartz

Securities Authorized for Issuance Under Equity Compensation Plans

The following table contains information about the

Company’s equity compensation plans as of December 31, 2024:

Equity Compensation Plan Information

securities to be

exercise price of

available for

future issuance

plans (excluding

Plan Category

Equity compensation plans approved by security holders

Equity compensation plans not approved by stockholders

See Part III, Item 12 “Equity Compensation

Plan Information” for certain information regarding our equity compensation plans.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity